Argenx
ARGX
#638
Rank
$31.87 B
Marketcap
$533.00
Share price
-0.62%
Change (1 day)
3.69%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Earnings for Argenx (ARGX)

Earnings in 2024 (TTM): -$0.24 B

According to Argenx 's latest financial reports the company's current earnings (TTM) are -$0.24 B. In 2023 the company made an earning of -$0.31 B an increase over its 2022 earnings that were of -$0.73 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Argenx from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$0.24 B-23.21%
2023 -$0.31 B-58.25%
2022 -$0.73 B
2019 -$0.2 B125.05%
2018 -$88.55 M132.12%
2017 -$38.15 M55.01%
2016 -$24.61 M32.9%
2015 -$18.52 M13.58%
2014 -$16.31 M46.29%
2013 -$11.15 M